Literature DB >> 23823657

In hematopoietic cells with a germline mutation of CBL, loss of heterozygosity is not a signature of juvenile myelo-monocytic leukemia.

M Strullu1, A Caye, B Cassinat, O Fenneteau, F Touzot, T Blauwblomme, R Rodriguez, S Latour, A Petit, V Barlogis, C Galambrun, T Leblanc, A Baruchel, C Chomienne, H Cavé.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23823657     DOI： 10.1038/leu.2013.203

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  7 in total

1.  Juvenile myelomonocytic leukemia due to a germline CBL Y371C mutation: 35-year follow-up of a large family.

Authors:  Anand Pathak; Alexander Pemov; Mary L McMaster; Ramita Dewan; Sarangan Ravichandran; Evgenia Pak; Amalia Dutra; Hyo Jung Lee; Aurelie Vogt; Xijun Zhang; Meredith Yeager; Stacie Anderson; Martha Kirby; Neil Caporaso; Mark H Greene; Lynn R Goldin; Douglas R Stewart
Journal:  Hum Genet       Date:  2015-05-05       Impact factor: 4.132

Review 2.  Turning the tide in myelodysplastic/myeloproliferative neoplasms.

Authors:  Michael W N Deininger; Jeffrey W Tyner; Eric Solary
Journal:  Nat Rev Cancer       Date:  2017-06-23       Impact factor: 60.716

3.  Unexpected Findings in a Child with Atypical Hemolytic Uremic Syndrome: An Example of How Genomics Is Changing the Clinical Diagnostic Paradigm.

Authors:  Eleanor G Seaby; Rodney D Gilbert; Gaia Andreoletti; Reuben J Pengelly; Catherine Mercer; David Hunt; Sarah Ennis
Journal:  Front Pediatr       Date:  2017-05-22       Impact factor: 3.418

Review 4.  Role of CBL Mutations in Cancer and Non-Malignant Phenotype.

Authors:  Davide Leardini; Daria Messelodi; Edoardo Muratore; Francesco Baccelli; Salvatore N Bertuccio; Laura Anselmi; Andrea Pession; Riccardo Masetti
Journal:  Cancers (Basel)       Date:  2022-02-08       Impact factor: 6.639

5.  Casitas B-lineage lymphoma Gene Mutation Ocular Phenotype.

Authors:  Christine Fardeau; Munirah Alafaleq; Marie-Adélaïde Ferchaud; Miguel Hié; Caroline Besnard; Sonia Meynier; Frédéric Rieux-Laucat; Damien Roos-Weil; Fleur Cohen; Isabelle Meunier
Journal:  Int J Mol Sci       Date:  2022-07-17       Impact factor: 6.208

6.  Immune dysregulation associated with co-occurring germline CBL and SH2B3 variants.

Authors:  Francesco Baccelli; Davide Leardini; Edoardo Muratore; Daria Messelodi; Salvatore Nicola Bertuccio; Maria Chiriaco; Caterina Cancrini; Francesca Conti; Fausto Castagnetti; Lucia Pedace; Andrea Pession; Ayami Yoshimi; Charlotte Niemeyer; Marco Tartaglia; Franco Locatelli; Riccardo Masetti
Journal:  Hum Genomics       Date:  2022-09-19       Impact factor: 6.481

7.  Molecular and phenotypic diversity of CBL-mutated juvenile myelomonocytic leukemia.

Authors:  Anna Hecht; Julia A Meyer; Astrid Behnert; Eric Wong; Farid Chehab; Adam Olshen; Aaron Hechmer; Catherine Aftandilian; Rukhmi Bhat; Sung Won Choi; Satheesh Chonat; Jason E Farrar; Mark Fluchel; Haydar Frangoul; Jennifer H Han; Edward A Kolb; Dennis J Kuo; Margaret L MacMillan; Luke Maese; Kelly W Maloney; Aru Narendran; Benjamin Oshrine; Kirk R Schultz; Maria L Sulis; David Van Mater; Sarah K Tasian; Wolf-Karsten Hofmann; Mignon L Loh; Elliot Stieglitz
Journal:  Haematologica       Date:  2022-01-01       Impact factor: 9.941
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.